Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study

BACKGROUND: Thymosin alpha 1 (Tα1) is widely used to treat patients with COVID-19 in China; however, its efficacy remains unclear. This study aimed to explore the efficacy of Tα1 as a COVID-19 therapy. METHODS: We performed a multicenter cohort study in five tertiary hospitals in the Hubei province...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jiao, Shen, Yanfei, Wen, Zhenliang, Xu, Qianghong, Wu, Zhixiong, Feng, Huibin, Li, Zhongyi, Dong, Xuan, Huang, Sisi, Guo, Jun, Zhang, Lidi, Chen, Yizhu, Li, Wenzhe, Zhu, Wei, Du, Hangxiang, Liu, Yongan, Wang, Tao, Chen, Limin, Teboul, Jean-Louis, Annane, Djillali, Chen, Dechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366398/
https://www.ncbi.nlm.nih.gov/pubmed/34408744
http://dx.doi.org/10.3389/fimmu.2021.673693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366398/
https://www.ncbi.nlm.nih.gov/pubmed/34408744
http://dx.doi.org/10.3389/fimmu.2021.673693

Ejemplares similares